Article
Genetically engineered mouse models may be an accurate predictor of how cancer-fighting drugs are delivered to melanoma patients, a new study demonstrates.
Defining Treatment Options for Managing Chronic Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Algorithm Proposes Targeted Lipase Monitoring for Pancreatic Adverse Events In Melanoma
Heart Transplant Recipients are More Susceptible to Skin Cancer